Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Liberty Live-C
LLYVK
5
American Express
AXP
AU Stock MarketDetailed Quotes
PER Percheron Therapeutics Ltd
- 0.010
- -0.001-9.09%
20min DelayTrading May 8 14:14 AET
10.87MMarket Cap-0.71P/E (Static)
0.011High0.010Low45.54KVolume0.011Open0.011Pre Close500.00Turnover0.14052wk High0.01%Turnover Ratio1.09BShares0.00552wk Low-0.016EPS TTM7.94MFloat Cap0.140Historical HighLossP/E (Static)794.38MShs Float0.005Historical Low-0.014EPS LYR9.09%Amplitude--Dividend TTM0.71P/B1Lot Size--Div YieldTTM
About Percheron Therapeutics Ltd Company
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.
Company Profile
SymbolPER
Company NamePercheron Therapeutics Ltd
Founded2000
MarketASX
Employees3
Fiscal Year Ends06-30
Address14 Wallace Avenue LEVEL 1
CityToorak
CountryAustralia
Zip Code3142
Phone+61 398278999
Websitehttps://www.percherontx.com
Share RegistryBOARDROOM PTY LIMITED
LEVEL 8, 210 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
(02) 9290 9600
Company Executives
- Name
- Position
- Salary
- James Garner
- Chief Executive Officer,Managing Director
- --
- Charmaine Gittleson
- Executive Chairman,Executive Director
- --
- Ben Gil Price
- Non-Executive Director
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting